Fernando D. F.

Investigator engages in clinical studies of blood‑derived cancers, spanning acute leukemias, plasma‑cell disorders and lymphoid neoplasms.

• acute myeloid leukemia (AML) and related myelodysplastic syndromes
• multiple myeloma including newly diagnosed and relapsed disease
• diffuse large B‑cell lymphoma (DLBCL)
• mantle cell lymphoma (MCL)
• chronic lymphocytic leukemia / small lymphocytic lymphoma

Efforts concentrate on novel agents and combination regimens to achieve deeper remissions.

Investigator addresses immune‑mediated conditions affecting multiple organ systems, with a particular interest in rheumatologic and hematologic autoimmunity.

• systemic lupus erythematosus and lupus nephritis
• idiopathic inflammatory myopathies such as dermatomyositis
• immune thrombocytopenia (ITP)
• autoimmune hemolytic anemia (warm type)
• atopic dermatitis and related skin inflammation

Studies evaluate immunomodulatory strategies to control disease activity and prevent organ damage.

Investigator participates in trials targeting heart disease, vascular pathology and metabolic dysfunction.

• acute myocardial infarction (AMI) and reperfusion therapy
• heart failure with reduced or preserved ejection fraction
• atherosclerotic cardiovascular disease (ASCVD) prevention
• type 2 diabetes mellitus and its complications
• obesity with associated metabolic risk

Research seeks to reduce cardiovascular events and improve metabolic control.

Investigator investigates respiratory conditions and serious infections, emphasizing acute and chronic lung pathology.

• acute respiratory distress syndrome (ARDS)
• nontuberculous mycobacterial lung infection (Mycobacterium avium complex)
• COVID‑19 and related viral pneumonitis
• pulmonary embolism and thromboembolic disease
• chronic obstructive pulmonary disease (COPD)

Efforts focus on innovative therapies to improve respiratory function and infection outcomes.